The amount of CD68+ macrophages in tumor stroma in different cohorts of patients (Chinese, Finnish, Swedish, Korean, UK, and USA cohorts) was an independent prognostic factor for reduced OS, DFS, and RFS of patients with breast cancer (45, 63, 68–71) (Table 2). Here, CD68 is linked to breast carcinoma.